Literature DB >> 21607171

Change in blood pressure and pulse pressure in preterm infants after treatment of patent ductus arteriosus with indomethacin.

Ui Joung Han1, Hwa Jin Cho, Young Kuk Cho, Young Youn Choi, Jae Sook Ma.   

Abstract

BACKGROUND AND OBJECTIVES: Patent ductus arteriosus (PDA) is associated with increased morbidity and mortality in premature infants. Therefore, an early diagnosis and treatment of a hemodynamically significant PDA are very important. A widened pulse pressure is considered to be a well known clinical sign of a PDA in older infants and children; however, whether this is also applicable in the case of preterm infants remains to be confirmed. The aims of this study were to investigate the change in blood pressure (BP) before and after medical treatment of a PDA with indomethacin and to evaluate if the change in the pulse pressure in preterm infants with a medically treated PDA could be used as a reliable clinical predictor of a hemodynamically significant PDA. SUBJECTS AND METHODS: Between January 2005 and June 2009, a retrospective analysis was performed in preterm infants with a hemodynamically significant PDA (PDA group, n=72) and preterm infants without a PDA (control group, n=72) at the Chonnam National University Hospital Neonatal Intensive Care Unit. The PDA was closed by treatment with indomethacin. The BP was compared between the two groups over the seven days after the first dose of indomethacin.
RESULTS: In preterm infants with a hemodynamically significant PDA, the mean systolic (55.1±6.0 mmHg) and diastolic BPs (31.4±6.2 mmHg) were lower than those in the controls (mean systolic BP 58.0±6.4 mmHg, mean diastolic BP 34.7±6.0 mmHg) before indomethacin treatment. When the ductus arteriosus was successfully closed by indomethacin treatment, there was a gradual increase in both the systolic and diastolic BPs without any change in the pulse pressure.
CONCLUSION: The results of this study show that a widened pulse pressure is not a useful clinical sign of a hemodynamically significant PDA in preterm infants. However, low systolic and diastolic BPs may be useful clinical signs of a hemodynamically significant PDA in preterm infants. If the systolic and diastolic BP is low, a PDA should be considered and echocardiography should be performed for early diagnosis and treatment.

Entities:  

Keywords:  Blood pressure; Ductus arteriosus, preterm; Preterm infant; Pulse pressure

Year:  2011        PMID: 21607171      PMCID: PMC3098413          DOI: 10.4070/kcj.2011.41.4.203

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


  17 in total

1.  HEMODYNAMIC BASIS FOR CLINICAL MANIFESTATIONS OF PATENT DUCTUS ARTERIOSUS.

Authors:  A M RUDOLPH; E M SCARPELLI; R J GOLINKO; N L GOOTMAN
Journal:  Am Heart J       Date:  1964-10       Impact factor: 4.749

2.  Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction.

Authors:  T Rakza; E Magnenant; S Klosowski; P Tourneux; A Bachiri; L Storme
Journal:  J Pediatr       Date:  2007-08-24       Impact factor: 4.406

3.  Change in blood pressure after treatment of patent ductus arteriosus with indomethacin.

Authors:  N Evans; P Iyer
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

4.  Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus.

Authors:  P Davis; S Turner-Gomes; K Cunningham; C Way; R Roberts; B Schmidt
Journal:  Arch Pediatr Adolesc Med       Date:  1995-10

Review 5.  Treatment of patent ductus arteriosus.

Authors:  Jonathan Wyllie
Journal:  Semin Neonatol       Date:  2003-12

6.  Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.

Authors:  S Shimada; T Kasai; M Konishi; T Fujiwara
Journal:  J Pediatr       Date:  1994-08       Impact factor: 4.406

7.  Indomethacin-induced early patent ductus arteriosus closure cannot be predicted by a decrease in pulse pressure.

Authors:  Ronit Lubetzky; Dror Mandel; Francis B Mimouni; Shmuel Diamant; Amir Birger; Mila Barak; Shaul Dollberg
Journal:  Am J Perinatol       Date:  2004-07       Impact factor: 1.862

8.  Doppler ultrasound and clinical evaluation in detection and grading of patient ductus arteriosus in neonates.

Authors:  H Hirsimäki; P Kero; O Wanne
Journal:  Crit Care Med       Date:  1990-05       Impact factor: 7.598

9.  Blood pressure ranges in premature infants: II. The first week of life.

Authors:  T Hegyi; M Anwar; M T Carbone; B Ostfeld; M Hiatt; A Koons; J Pinto-Martin; N Paneth
Journal:  Pediatrics       Date:  1996-03       Impact factor: 7.124

10.  Effect of patency of the ductus arteriosus on blood pressure in very preterm infants.

Authors:  N Evans; J Moorcraft
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

View more
  3 in total

1.  Impact of Medical Treatment of Hemodynamically Significant Patent Ductus Arteriosus on Cerebral and Renal Tissue Oxygenation Measured by Near-Infrared Spectroscopy in Very Low-Birth-Weight Infants.

Authors:  Jūratė Navikienė; Arūnas Liubšys; Ernestas Viršilas; Tadas Žvirblis; Augustina Jankauskienė
Journal:  Medicina (Kaunas)       Date:  2022-03-25       Impact factor: 2.948

2.  Systemic hypertension requiring treatment in the neonatal intensive care unit.

Authors:  Raj Sahu; Hariyadarshi Pannu; Robert Yu; Sanjay Shete; John T Bricker; Monesha Gupta-Malhotra
Journal:  J Pediatr       Date:  2013-02-07       Impact factor: 4.406

3.  Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.

Authors:  Jonathan L Slaughter; Clifford L Cua; Jennifer L Notestine; Brian K Rivera; Laura Marzec; Erinn M Hade; Nathalie L Maitre; Mark A Klebanoff; Megan Ilgenfritz; Vi T Le; Dennis J Lewandowski; Carl H Backes
Journal:  BMC Pediatr       Date:  2019-09-13       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.